Identification of DLEC1 D215N Somatic Mutation in Formalin Fixed Paraffin Embedded Melanoma and Melanocytic Nevi Specimens
Open Access
- 13 October 2013
- journal article
- research article
- Published by Wiley in Journal of Skin Cancer
- Vol. 2013, 1-4
Abstract
DLEC1 has been suggested as a tumor suppressor gene in several cancers. DLEC1 D215N somatic mutation (COSM36702) was identified in a melanoma cell line through whole genome sequencing. However, little is known about the implication and prevalence of this mutation in primary melanomas or in melanocytic nevi. The aim of this study was to genotype DLEC1 D215N mutation in melanoma tissue and melanocytic nevi samples to confirm its occurrence and to estimate its prevalence. Primary melanomas () paired with synchronous or asynchronous metastases () from 81 melanoma patients and melanocytic nevi () were screened for DLEC1 D215N mutation. We found the mutation in 3 primary melanomas and in 2 melanocytic nevi, corresponding to a relatively low prevalence (3.7% and 7.1%, resp.). The pathogenic role of DLEC1 215N mutation is unclear. However, since the mutation has not been previously described in general population, its involvement in nevogenesis and melanoma progression remains a possibility to be clarified in future studies.
Keywords
This publication has 20 references indexed in Scilit:
- Epigenetic silencing of the 3p22 tumor suppressor DLEC1 by promoter CpG methylation in non-Hodgkin and Hodgkin lymphomasJournal of Translational Medicine, 2012
- Exome sequencing identifies GRIN2A as frequently mutated in melanomaNature Genetics, 2011
- Aberrant Promoter Methylation ofDLEC1, a Critical 3p22 Tumor Suppressor for Renal Cell Carcinoma, is Associated With More Advanced Tumor StageJournal of Urology, 2010
- Frequent Epigenetic Inactivation of Deleted in Lung and Esophageal Cancer 1 Gene by Promoter Methylation in Non–Small-Cell Lung CancerClinical Lung Cancer, 2010
- Evidence of a tumour suppressor function for DLEC1 in human breast cancer.2010
- A comprehensive catalogue of somatic mutations from a human cancer genomeNature, 2009
- Novel Integrative Methods for Gene Discovery Associated With Head and Neck Squamous Cell Carcinoma DevelopmentJAMA Otolaryngology–Head & Neck Surgery, 2009
- DLEC1 is a functional 3p22.3 tumour suppressor silenced by promoter CpG methylation in colon and gastric cancersBritish Journal of Cancer, 2009
- Predicting Deleterious Amino Acid SubstitutionsGenome Research, 2001
- Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome.2000